Tymlos Drug Interactions: What to Avoid and What to Tell Your Doctor

Before starting any new medication, it's important to know how it might interact with other drugs, supplements, and health conditions you already have. Tymlos (abaloparatide) has a favorable interaction profile compared to many medications — but there are still important considerations patients and caregivers should be aware of.

This guide covers what the prescribing information and clinical evidence say about Tymlos drug interactions, what supplements require attention, and what conditions affect how Tymlos should be used.

Does Tymlos Have Significant Drug-Drug Interactions?

Relatively speaking, Tymlos has a clean drug interaction profile. The FDA prescribing information states that abaloparatide is not known to inhibit or induce major drug-metabolizing enzyme systems, and it does not significantly interact with renal drug transporters including OAT1, OAT3, OCT2, MATE1, or MATE2K. This means Tymlos is unlikely to interfere with the pharmacokinetics of most common medications.

However, there are important clinical considerations related to medications that affect calcium levels, blood pressure, and bone metabolism.

Medications That Should NOT Be Used With Tymlos

The following drug categories should not be used concurrently with Tymlos:

Other anabolic bone agents (romosozumab/Evenity, teriparatide/Forteo): Concurrent use of two anabolic agents is not recommended. No benefit has been demonstrated and the combination has not been adequately studied for safety.

Bisphosphonates (alendronate, risedronate, zoledronic acid) during Tymlos therapy: Combining Tymlos with a bisphosphonate during the anabolic phase is not recommended. Bisphosphonates are used after Tymlos, not during it.

Denosumab (Prolia) concurrent use: The RANKL inhibitor denosumab is not recommended simultaneously with Tymlos. Denosumab is typically initiated after completing Tymlos to preserve bone gains.

Medications That May Increase Tymlos Side Effect Risk

Antihypertensive medications (blood pressure drugs): Tymlos can cause orthostatic hypotension (drop in blood pressure on standing) within 4 hours of injection. If you take antihypertensives, you may be more susceptible to this effect. Tell your doctor about all blood pressure medications, and be especially careful during the first few doses.

Diuretics (water pills like hydrochlorothiazide, furosemide): Some diuretics affect calcium excretion. Thiazide diuretics reduce urinary calcium excretion (may be beneficial); loop diuretics increase it (may worsen hypercalciuria from Tymlos). Discuss with your doctor.

Medications that cause hypercalcemia: Vitamin D toxicity (from very high-dose supplements) or lithium carbonate can raise blood calcium. Because Tymlos also has the potential to elevate calcium, combination with other hypercalcemia-inducing agents requires careful monitoring.

Digitalis (digoxin): Hypercalcemia can increase sensitivity to digoxin, potentially leading to arrhythmias. If you take digoxin for a heart condition, your doctor should monitor calcium levels closely while you're on Tymlos.

Supplement Interactions with Tymlos

Calcium supplements: Calcium supplementation is often recommended alongside Tymlos to support bone building. However, excessive calcium supplementation combined with Tymlos can increase the risk of hypercalcemia. Take only the amount your doctor recommends (typically 1,000–1,200 mg/day total from diet and supplements).

Vitamin D supplements: Adequate vitamin D is essential for bone health and is recommended with Tymlos. However, very high doses of vitamin D (toxicity) can cause hypercalcemia. Follow your doctor's dosing guidance, and have your vitamin D levels tested if you're not sure where you stand.

Strontium supplements: Strontium ranelate and strontium supplements are sometimes marketed for bone health. There is no established safe combination with Tymlos; discuss with your doctor before taking strontium.

Medical Conditions That Affect Tymlos Use

Kidney disease: No dose adjustment is required for mild, moderate, or severe renal impairment. However, patients with severe renal impairment or urolithiasis (kidney stones) should be monitored more closely for hypercalciuria.

Primary hyperparathyroidism: Tymlos is not recommended in patients with existing hypercalcemia or conditions that cause elevated calcium, as it could worsen those levels.

Cardiovascular disease: Monitor blood pressure and heart rate in patients with pre-existing cardiovascular conditions, given the potential for orthostatic hypotension and palpitations.

What to Tell Your Doctor Before Starting Tymlos

Before starting Tymlos, provide your doctor with a complete list of:

All prescription medications (including other osteoporosis drugs, blood pressure drugs, heart medications, diuretics)

All OTC supplements, especially calcium, vitamin D, magnesium, and any bone health products

Any history of kidney stones or kidney disease

Any history of Paget's disease, bone cancer, or radiation therapy to the skeleton

Any history of hypercalcemia or hyperparathyroidism

Prior duration of teriparatide use (counts toward the cumulative 24-month PTH analog lifetime limit)

For a full review of Tymlos side effects and safety, see our guide on Tymlos side effects: what to expect and when to call your doctor.

If you're looking for a pharmacy with Tymlos in stock, medfinder can help by calling pharmacies near you to check availability.